retatrutide triple agonist obesity trial 🚨 HOT OFF THE PRESS: Phase 3 data has arrived — and the medicine world is paying attention. In Lilly's TRIUMPH-1 trial, participants receiving the highest dose achieved an average Another Promising Medication (Retatrutide) for

Regen Wellness Vitamins - a one-stop shop for functional medicine solutions: practitioner-grade vitamins, peptides, labs & biohacking tools

As use of GLP-1 receptor agonists continues to expand, the integration of conventional clinical evidence with large-scale observational data may offer a more complete picture of how these therapies affect patients in routine practice

Extension participants continued treatment for an additional 24 weeks (to 104 weeks total) and were transitioned to their maximally tolerated dose of 9 or 12 mg

It does not cause gastrointestinal symptoms

Conclusion PROM developers consider it feasible to involve children younger than 8-years-old in the qualitative development of PROMs in QoL research

If you used semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) for weight loss and did not see good changes, there may be another option for you